Heme Iron Polypeptide in Iron Deficiency Anemia of Pregnancy: Current Evidence

HTML  XML Download Download as PDF (Size: 766KB)  PP. 420-431  
DOI: 10.4236/ojog.2017.74044    2,884 Downloads   8,030 Views  Citations

ABSTRACT

Iron deficiency is the most common nutritional deficiency leading to anemia in pregnancy. Conventionally, non-heme form of iron salts has been the mainstay of treatment. However, patient compliance is an important concern with existing oral iron therapy due to gastrointestinal side effects. Heme iron, a better bioavailable and tolerable form of iron can be suitable form of iron for supplementation in pregnancy. Evidence suggests its utility in pregnancy for treatment of iron deficiency anemia with benefits extending to postpartum period. Effective transfer across placenta to fetus further supports its utility in pregnancy. This review discusses in details the absorption kinetics along with clinical evidence on efficacy, safety, and tolerability of heme-iron supplementation in iron deficiency anemia of pregnancy.

Share and Cite:

Pal, B. , Deshpande, H. , Sundari, T. , Biniwale, P. , Shah, K. , Goel, S. , Khurana, A. , Qamra, A. , Motlekar, S. and Barkate, H. (2017) Heme Iron Polypeptide in Iron Deficiency Anemia of Pregnancy: Current Evidence. Open Journal of Obstetrics and Gynecology, 7, 420-431. doi: 10.4236/ojog.2017.74044.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.